Attached files
| file | filename |
|---|---|
| EX-23.1 - EX-23.1 - BioPlus Acquisition Corp. | d153053dex231.htm |
| EX-10.5 - EX-10.5 - BioPlus Acquisition Corp. | d153053dex105.htm |
| EX-10.4 - EX-10.4 - BioPlus Acquisition Corp. | d153053dex104.htm |
| EX-10.2 - EX-10.2 - BioPlus Acquisition Corp. | d153053dex102.htm |
| EX-3.1 - EX-3.1 - BioPlus Acquisition Corp. | d153053dex31.htm |
| S-1 - S-1 - BioPlus Acquisition Corp. | d153053ds1.htm |
Exhibit 99.3
Consent to be Named as a Director
In connection with the filing by BioPlus Acquisition Corp. of the Registration Statement on Form S-1 (the “Registration Statement”) with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), I hereby consent, pursuant to Rule 438 of the Securities Act, to being named as a member of the board of directors of BioPlus Acquisition Corp. in the Registration Statement and any and all amendments and supplements thereto. I also consent to the filing of this consent as an exhibit to such Registration Statement and any amendments thereto.
| /s/ Alan C. Mendelson | ||||||
| Date: July 15, 2021 | Name: Alan C. Mendelson |
Consent to be Named as a Director Nominee
In connection with the filing by BioPlus Acquisition Corp. of the Registration Statement on Form S-1 (the “Registration Statement”) with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), I hereby consent, pursuant to Rule 438 of the Securities Act, to being named as a nominee to the board of directors of BioPlus Acquisition Corp. in the Registration Statement and any and all amendments and supplements thereto. I also consent to the filing of this consent as an exhibit to such Registration Statement and any amendments thereto.
| /s/ Louis G. Lange | ||||||
| Date: July 15, 2021 | Name: Louis G. Lange, M.D., Ph.D. |
Consent to be Named as a Director Nominee
In connection with the filing by BioPlus Acquisition Corp. of the Registration Statement on Form S-1 (the “Registration Statement”) with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), I hereby consent, pursuant to Rule 438 of the Securities Act, to being named as a nominee to the board of directors of BioPlus Acquisition Corp. in the Registration Statement and any and all amendments and supplements thereto. I also consent to the filing of this consent as an exhibit to such Registration Statement and any amendments thereto.
| /s/ Stephen Sherwin | ||||||
| Date: July 15, 2021 | Name: Stephen Sherwin, M.D. |
Consent to be Named as a Director Nominee
In connection with the filing by BioPlus Acquisition Corp. of the Registration Statement on Form S-1 (the “Registration Statement”) with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), I hereby consent, pursuant to Rule 438 of the Securities Act, to being named as a nominee to the board of directors of BioPlus Acquisition Corp. in the Registration Statement and any and all amendments and supplements thereto. I also consent to the filing of this consent as an exhibit to such Registration Statement and any amendments thereto.
| /s/ Jonathan Rigby | ||||||
| Date: July 15, 2021 | Name: Jonathan Rigby |
Consent to be Named as a Director Nominee
In connection with the filing by BioPlus Acquisition Corp. of the Registration Statement on Form S-1 (the “Registration Statement”) with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), I hereby consent, pursuant to Rule 438 of the Securities Act, to being named as a nominee to the board of directors of BioPlus Acquisition Corp. in the Registration Statement and any and all amendments and supplements thereto. I also consent to the filing of this consent as an exhibit to such Registration Statement and any amendments thereto.
| /s/ Glen Giovanetti | ||||||
| Date: July 15, 2021 | Name: Glen Giovanetti |